Intervention

Sham transcranial direct current stimulation

ClinicalTrials.gov intervention label

Clinical trials8

Recruiting3

Common conditions12

Lead sponsors shown7

Clinical trials

8 shown

Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current StimulationNCT07534397 · 2026-09-15

Home-Based tDCS Treatment Of Major Depressive DisorderNCT06976697 · 2025-06-27

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current StimulationNCT05958381 · 2023-10-18

Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer SurvivorsNCT07083518 · 2025-05-29

ACTIVE_NOT_RECRUITING

Speech and Voice Outcomes Following HD-tDCS Over the Left SMANCT06245070 · 2025-02-02

NOT_YET_RECRUITING

Cognitive Improvement Through tDCS for Patients With Multiple SclerosisNCT04667221 · 2020-12-08

Cerebellar Transcranial Direct Current Stimulation in Parkinson's DiseaseNCT04046055 · 2019-12-01

Cognitive Training With and Without tDCS to Improve Cognition in HIVNCT02647645 · 2015-09-01

Common conditions

Parkinson Disease2 Brain Stimulation1 Breast Cancer Survivor1 Cerebellum1 Cognitive Impairment1 HIV1 Major Depressive Disorder (MDD)1 Mild Neurocognitive Disorder1 Multiple Sclerosis1 Multiple Sclerosis, Relapsing-Remitting1 PARKINSON DISEASE (Disorder)1 Transcranial Direct Current Stimulation (tDCS)1

Leading sponsors

The University of Texas at Dallas2 Anhui Medical University1 Louisiana State University and A&M College1 Nova Southeastern University1 Sooma Medical Inc1 Thorsten Rudroff1 University Medicine Greifswald1

Trial status mix

RECRUITING3

ACTIVE_NOT_RECRUITING1

COMPLETED1

NOT_YET_RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

NA8

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.